Pentasa
Product Images NDC 69189-0189

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pentasa (NDC 69189-0189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mesalamine Cr 250 mg Capsule Label (6918901891)

Packaging label for Pentasa 250 mg capsule containing mesalamine. The label shows manufacturer as Shire and includes lot numbers, expiration date of 11/02/2016, and NDC 69189-0189. The labeler is Avera McKennan Hospital from Sioux Falls, SD.*

FDA Label Image

Pentasa-chem (Pentasa 1)

Chemical structure diagram showing a benzene ring with attached carboxyl (COOH), hydroxyl (OH), and amino (NH2) groups, representing the active ingredient's molecular structure associated with the product Pentasa from Avera McKennan Hospital.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.